Vvus stock price today
Mar 09, 2019 · VIVUS, Inc. (NASDAQ:VVUS) shareholders will doubtless be very grateful to see the share price up 58% in the last quarter.But will that repair the damage for the weary investors who have owned this stock as it declined over half a decade? Probably not. Like a ship taking on water, the share price has sunk 92% in that time. VVUS Stock News - Fidelity Mar 26, 2020 · - Company to host conference call today at 4:30pm ET - VIVUS (VVUS), Inc. , a biopharmaceutical company, today reported financial results for the quarter and fiscal year ended December 31, 2019 and provided a business update. Fiscal year 2019 represents our first full year of operating results as a fully integrated business and clinical team, said John Amos, VIVUS Chief … VVUS Stock Price Quote & News - VIVUS | Robinhood
22 Nov 2019 Imagine if you held VIVUS, Inc. (NASDAQ:VVUS) for half a decade as the share price tanked 91%. Even worse, it's down 32% in about a month,
What Is Moving VIVUS, Inc. (VVUS) Today – Find News Apr 01, 2020 · An interesting stock that came up in some of our conversations today is VIVUS, Inc. (NASDAQ:VVUS). At current price of $1.48, the shares have already lost -2.12 points (-58.89% lower) from its previous close of $3.6. VVUS:NASDAQ GS Stock Quote - VIVUS Inc - Bloomberg Markets Stock analysis for VIVUS Inc (VVUS:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
Find real-time VVUS - Vivus Inc stock quotes, company profile, news and forecasts from CNN Business.
VVUS VIVUS, Inc. Stock Quote - FINVIZ.com - Stock Screener VIVUS, Inc. operates as a specialty pharmaceutical company primarily in the United States and the European Union. The company offers Qsymia for the treatment of obesity as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body-mass index of 30 or greater (obese patients) or 27 or greater (overweight patients) in Vivus (VVUS) Stock Message Board - InvestorsHub Mar 26, 2020 · MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Nov. 5, 2007--VIVUS, Inc. (NASDAQ: VVUS), a pharmaceutical company dedicated to the development and commercialization of novel therapeutic products, today announced that it has successfully concluded communications with the U.S. Food and Drug Administration (FDA), under the Special Protocol Assessment VVUS Archives - Stock Price Nov 21, 2019 · Subscribe Now & Begin Receiving Stock News, Articles, Trade Alerts & MORE, all 100% FREE! We are your #1 source for all things Stocks, Subscribe Below! Get stock alerts, news & stock related alerts straight to your inbox!
Nov 21, 2019 · Subscribe Now & Begin Receiving Stock News, Articles, Trade Alerts & MORE, all 100% FREE! We are your #1 source for all things Stocks, Subscribe Below! Get stock alerts, news & stock related alerts straight to your inbox!
VVUS, $VVUS, VIVUS Inc stock technical analysis with charts, breakout and price targets, https://stockconsultant.com/?VVUS Quote 0.95 +0.03,+3.3%. Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it share price. View recent trades and share price information for Vivus Inc USD0. 001. for an ISA. Discover three shares to consider for this year's allowance.
Nov 09, 2019 · Corbus Pharmaceuticals Holdings Inc. analyst estimates by MarketWatch. View CRBP revenue estimates and earnings estimates, as well as analyst recommendations.
Fifth Third Bancorp Common Stock (FITB) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. VVUS Historical Stock Prices Vivus (VVUS) has the following price history information. Looking back at VVUS historical stock prices for the last five trading days, on March 12, 2020, VVUS opened at $0.99, traded as high as $1.18 and as low as $0.95, and closed at $1.14. Trading volume was a total of 236.60K shares.
CRBP | Corbus Pharmaceuticals Holdings Inc. Analyst ... Nov 09, 2019 · Corbus Pharmaceuticals Holdings Inc. analyst estimates by MarketWatch. View CRBP revenue estimates and earnings estimates, as well as analyst recommendations. Vivus, Inc (VVUS) Stock: Price, Quote and Overview | Stock ... Get real-time information and analysis on Vivus, Inc. (VVUS) stock today, including the current stock price quote and key metrics.